[..] Another company from Tel Aviv, Alpha Tau Medical, has partnered with Japanese biotechnology startup HekaBio to release radiation therapy equipment in Japan in 2021, at the earliest.
The product is designed to treat patients with breast, skin and other solid cancers. Unlike most such equipment, Alpha Tau's "radioactive seeds" emit alpha rays from inside the body. These rays are more powerful than other forms of radiation but are less likely to damage surrounding cells.
HekaBio CEO Robert Claar has high hopes the device will prove practical. "We can provide this therapy at lower prices than external radiation therapies," he said. [...]
